Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.

Slides:

Advertisements

Similar presentations

Wu et al., Supplementary Fig 1 Supplementary Figure 1: The depletion of BRG1 in HeLa cells has no effect on cell proliferation. Sh- empty vector was used.

Advertisements

miR-133a positively regulated p53/p21 pathway.

A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC

Involvement of SR Proteins in mRNA Surveillance

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Supplemental Figure S1. Expression of MYOCD, MYOCD ceRNA and miRNAs

Pioglitazone inhibits aromatase expression in human preadipocytes.

ATF5 transactivates Egr-1 via the ATF5CON sites in the Egr-1 promoter.

BRCA1 PARsylation is required for normal HRR tuning.

Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.

Effect of Nf1 knockdown on Wnt pathway in MSC80 cells.

Inhibition of β-catenin by the Smad4/BMP pathway.

Strategy for mutant telomere synthesis in human cancer cells.

Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

RXRa serves as a carrier for TR3 translocation initiated by 9-cis retinoic acid. RXRa serves as a carrier for TR3 translocation initiated by 9-cis retinoic.

PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. A,

Allopurinol up-regulates DR5 expression in PC-3 and DU145 cells.

JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.

CREB1 promotes the induction of endogenous ERα target genes.

Effect of the siRNA-mediated knockdown of endogenous MARCH8 on the expression levels of MARCH8 substrates, TfR and CD98, in HepG2 cells. Effect of the.

Effects of low-level expression of mutant-template telomerase RNA in MCF-7 breast cancer cells. Effects of low-level expression of mutant-template telomerase.

DNA damage foci accumulate at a subset of telomeres in cells expressing a mutant-template telomerase RNA. Immunostaining was done for telomere-protective.

co-IP of LEDGF/p75 and MeCP2.

Quantification of NMT knockdown.

Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.

A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.

Epigenetic regulation of p16INK4a in human gastric cancer.

BORIS mRNA expression in DNMT deficient HCT116 cell lines.

Induction of CDCP1 is regulated by Ras in NSCLC cells.

Validation of the screen hits.

Competition between FLYWCH1/β-catenin and TCF4/β-catenin complexes for their interaction to Tcf-DNA-binding sites. Competition between FLYWCH1/β-catenin.

CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.

A, top, representative Western blot for Ku70 in MCF7 cell extracts following siRNA knockdown of Ku70, compared with siRNA control. A, top, representative.

Expression of CRC stem cell markers and L1 in CRC cells.

Knockdown of PKM2 suppressed TPA-induced skin cell transformation.

A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.

High-throughput siRNA screening results and corresponding patient gene expression data for PP2A subunits. High-throughput siRNA screening results and corresponding.

TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.

Expression pattern of TLR-4 and MyD88 in EOC cells.

Targeting DCLK1 by miRNA-137.

Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.

Effect of hydrogen peroxide on survival and transcriptional activation of TFF1 in established cell lines from the following human tumor tissues: breast.

A and B, comparison of time course of TFF1 mRNA induction under estrogen-withdrawn (denoted ph−/ES−) and estrogenic medium (denoted ph+/ES+) conditions.

Pirh2 represses p73-dependent transactivation.

Bim expression and activation correlates with reduced Notch3 expression and increased anoikis. Bim expression and activation correlates with reduced Notch3.

SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.

The effects of HDAC2 knockdown on cell-cycle proteins.

PD-L1 is expressed in breast cancer.

BCG uptake by bladder cancer cells requires activated Pak1.

Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.

Substitution of endogenous Reptin with D299N mutant leads to HuH7 cell growth arrest. Substitution of endogenous Reptin with D299N mutant leads to HuH7.

Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.

Transcriptional activity and growth of mutant ER in a breast cancer cell line. Transcriptional activity and growth of mutant ER in a breast cancer cell.

Western blot analysis for bFGF expression in human glioma cell lines.

Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter. Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter.

Expression data from genes involved in regulation of transit through the cell cycle in response to treatment with E2 and OHT. A. Expression data from genes.

Fig. 4 Dcr-2 binds to the 3′UTR of Toll mRNA.

The interaction of PALB2 with BRCA1 is required for the assembly of PALB2, BRCA2, and RAD51 nuclear foci. The interaction of PALB2 with BRCA1 is required.

Transfection efficiency and PicoGreen cell survival assays.

Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.

Expression of chemokine receptors in A-498 cell line.

Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.

Effects of NMT siRNAs on MARCKS and c-Src.

Knockdown of NR4A1 induces endoplasmic reticulum stress–mediated apoptosis by increasing ROS production in pancreatic cancer cells. Knockdown of NR4A1.

I3C reduces the level of Cdc25A protein in breast cancer cells.

miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.

Proteome changes associated with CHCHD2 expression in NSCLC cells.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

Silencing E4BP4 abrogates the promoting effect of SMAD3 knockdown on IFNγ production in NK-92 cells. Silencing E4BP4 abrogates the promoting effect of.

Presentation transcript:

Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Northern blot analysis of RNA extracted from a human cancer cell line, MCF-7. The human telomerase RNA, a non-mRNA, can be efficiently knocked down by expression of a short hairpin RNA from a lentiviral construct. GFP lane, Northern blot analysis of RNA from cells expressing GFP alone from the control lentiviral vector [adapted from Li et al. (7)]. Elizabeth H. Blackburn Mol Cancer Res 2005;3:477-482 ©2005 by American Association for Cancer Research